Carleone Joseph's most recent trade in Sensient Technologies Corp. was a trade of 370 Deferred Stock done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 370 | 22,305 | - | - | Deferred Stock | |
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2025 | 1,386 | 21,285 (0%) | 0% | 0 | Common Stock | |
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 490 | 21,840 | - | - | Deferred Stock | |
| Sensient Technologies Corp. | Carleone Joseph | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 512 | 21,222 | - | - | Deferred Stock | |
| Avid Bioservices Inc | Joseph Carleone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2024 | 26,756 | 130,324 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Joseph Carleone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2024 | 26,756 | 0 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2024 | 8,147 | 8,147 | - | - | Restricted Stock Units | |
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 455 | 20,602 | - | - | Deferred Stock | |
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 492 | 20,038 | - | - | Deferred Stock | |
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2024 | 1,436 | 19,579 (0%) | 0% | 0 | Common Stock | |
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 527 | 19,442 | - | - | Deferred Stock | |
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 553 | 18,798 | - | - | Deferred Stock | |
| Avid Bioservices Inc | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 26,756 | 26,756 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Joseph Carleone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 9,612 | 103,568 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Joseph Carleone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 9,612 | 0 | - | - | Restricted Stock Units | |
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 624 | 18,120 | - | - | Deferred Stock | |
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 513 | 17,381 | - | - | Deferred Stock | |
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 1,222 | 17,817 (0%) | 0% | 0 | Common Stock | |
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 477 | 16,773 | - | - | Deferred Stock | |
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 500 | 16,207 | - | - | Deferred Stock | |
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 526 | 15,621 | - | - | Deferred Stock | |
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 453 | 15,016 | - | - | Deferred Stock | |
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 1,060 | 16,358 (0%) | 0% | 0 | Common Stock | |
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 379 | 14,494 | - | - | Deferred Stock | |
| Avid Bioservices Inc | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 4,632 | 4,632 | - | - | Restricted Stock Units | |
| Avid Bioservices Inc | Joseph Carleone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2021 | 2,379 | 69,324 (0%) | 0% | - | Common Stock, $0.001 par value | |
| Avid Bioservices Inc | Joseph Carleone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2021 | 2,379 | 0 | - | - | Restricted Stock Units | |
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 362 | 13,618 | - | - | Deferred Stock | |
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 381 | 13,197 | - | - | Deferred Stock | |
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2021 | 1,105 | 15,113 (0%) | 0% | 0 | Common Stock | |
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 423 | 12,759 | - | - | Deferred Stock | |
| Avid Bioservices Inc | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2020 | 10,030 | 124,305 | - | - | Stock Option (right to buy) | |
| Avid Bioservices Inc | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2020 | 2,379 | 2,379 | - | - | Restricted Stock Units | |
| Sensient Technologies Corp. | Joseph Carleone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 571 | 11,764 | - | - | Deferred Stock |